Does Family Caregiver Burden Differ Between Elderly and Younger Caregivers in Supporting Dying Patients With Cancer? An Italian StudyRoberta Spatuzzi, Anna Vespa, Maria Velia Giulietti et al.|American Journal of Hospice and Palliative Medicine®|2019Cited by 33
Reduced dose intensity of docetaxel plus capecitabine as second-line palliative chemotherapy in patients with metastatic gastric cancer: a phase II studyGerardo Rosati, Luigi Manzione, Domenico Bilancia et al.|Annals of Oncology|2007Cited by 24
XELOX and bevacizumab followed by single-agent bevacizumab as maintenance therapy as first-line treatment in elderly patients with advanced colorectal cancer: the boxe studyGerardo Rosati, Domenico Bilancia, Antonio Avallone et al.|Cancer Chemotherapy and Pharmacology|2012Cited by 23
Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer Aged at Least 75 Years: A Post-Hoc Subgroup Analysis of Three Phase II TrialsGerardo Rosati, Roberto Bordonaro, Stefano Cordio et al.|Cancers|2019Cited by 6
Reduced-dose of doublet chemotherapy combined with anti-EGFR antibodies in vulnerable older patients with metastatic colorectal cancer: Data from the REVOLT studyGerardo Rosati, Domenico Bilancia, Domenico Corsi et al.|Journal of Geriatric Oncology|2021Cited by 5